2 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 2 |
Follow UTUC: new trials by email Literature Review of UTUC trials Research Report on UTUC
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neoadjuvant Gemcitabine Plus Trastuzumab Rezetecan in HER2-positive UTUC Trastuzumab Rezetecan, Gemcitabine, Radical nephroureterectomy - UTUC | Phase 2 | Recruiting | Zhiquan Hu | 54 | 2026-08-15 | 2026-08-03 |
| A Study of RC48-ADC Combined with JS001 for Postoperative Adjuvant Treatment of Upper Tract Urothelial Carcinoma RC48-ADC and JS001 - Carcinoma, Upper Tract Urothelial Carcinoma | Phase 2 | Recruiting | Jinling Hospital, China | 30 | 2022-11-23 | 2025-01-22 |
Carcinoma (1)
Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Glandular and Epithelial (1)
Gemcitabine (1)
Jinling Hospital, China (1) · Zhiquan Hu (1)
China (2)